Supportive Care in Hypertensive Crises

Supportive Care, Complication Prevention, and Monitoring in Hypertensive Crises

Objectives Icon A checkmark inside a circle, symbolizing achieved goals.

Learning Objective

  • Recommend supportive care and monitoring strategies to manage complications of hypertensive crises and its treatment.

I. Indications and Considerations for Supportive Care Measures

Short summary: In hypertensive emergencies, adjunctive supportive care—ventilatory and hemodynamic—preserves organ perfusion during blood-pressure control.

A. Mechanical Ventilation

Indications

  • Respiratory failure (PaO₂/FiO₂ <200, refractory hypoxemia)
  • Airway protection: decreased consciousness (GCS ≤8) from encephalopathy or intracranial hemorrhage
  • Cardiogenic pulmonary edema unresponsive to noninvasive support

Ventilation strategy

  • Lung-protective tidal volume: 6 mL/kg predicted body weight
  • PEEP: lowest level to maintain SpO₂ ≥92%
  • Avoid excessive hyperventilation in neurologic injury (target PaCO₂ 35–40 mm Hg)
  • Minimize sedation to facilitate neurologic exams and reduce delirium risk

Monitoring

  • Arterial blood gases every 4–6 h or after ventilator changes
  • Plateau pressure <30 cmH₂O, track respiratory compliance
Pearl Icon A shield with an exclamation mark, indicating a clinical pearl. Key Clinical Pearls: Mechanical Ventilation
  • In intracerebral hemorrhage or hypertensive encephalopathy, abrupt PaCO₂ drops worsen cerebral ischemia.
  • Early intubation may prevent aspiration in fluctuating mental status; weigh risks of sedation.

Case Vignette

A 70-year-old with ICH and GCS 7 is intubated; set Vt to 6 mL/kg PBW, maintain PaCO₂ at 38 mm Hg, and perform daily spontaneous breathing trials.

B. Hemodynamic Support

Indications

  • Hypotension from over-reduction of BP (MAP <65 mm Hg)
  • Cardiogenic shock in acute pulmonary edema

Fluid resuscitation

  • Isotonic crystalloid boluses (250–500 mL) guided by dynamic indices (stroke volume variation, passive leg raise)
  • Avoid fluid overload in heart failure or renal impairment

Vasopressors/inotropes

  • Norepinephrine first-line for persistent hypotension: start 0.05 µg/kg/min, titrate to MAP ≥65 mm Hg
  • Low-dose vasopressin (0.03 units/min) adjunct in refractory vasodilatory shock
  • Dobutamine for cardiogenic shock with adequate BP: 2–10 µg/kg/min

Mechanical circulatory support (refractory cases)

  • IABP, Impella, VA-ECMO as bridges in reversible cardiac failure

Invasive monitoring

  • Arterial line: real-time BP for IV antihypertensive titration
  • Central venous catheter: vasopressor delivery, CVP trending
  • Pulmonary artery catheter: reserved for mixed or unclear shock
Pearl Icon A shield with an exclamation mark, indicating a clinical pearl. Key Clinical Pearls: Hemodynamic Support
  • Always secure invasive BP monitoring before aggressive IV antihypertensives.
  • In post-nitroprusside hypotension, restore MAP with norepinephrine rather than rapid fluid loading.

II. Prevention of ICU-Related Complications

Short summary: Prophylactic measures minimize thrombotic, gastrointestinal, and infectious risks during ICU stays.

A. VTE Prophylaxis

Table 1: VTE Prophylaxis Agents and Monitoring
Agent Dosing Monitoring & Adjustments
Low-molecular-weight heparin (enoxaparin) 40 mg SC q24h (reduce to 30 mg if CrCl <30 mL/min) Platelet count q2–3 days (HIT surveillance); Anti-Xa levels in extremes of weight or renal dysfunction
Unfractionated heparin 5,000 units SC q8–12h Platelet count q2–3 days (preferred if high bleeding risk or renal failure)

Contraindications

  • Active bleeding
  • Platelets <50 ×10⁹/L
  • Recent hemorrhagic stroke (relative, weigh risk/benefit)

B. Stress Ulcer Prophylaxis

Indications

  • Mechanical ventilation >48 h
  • Coagulopathy: INR >1.5 or platelets <50 ×10⁹/L
Table 2: Stress Ulcer Prophylaxis Agents and Monitoring
Agent Dosing Risks and Monitoring
Pantoprazole (PPI) 40 mg IV q24h Watch for C. difficile, hospital-acquired pneumonia. Discontinue when risk factors resolve.
Famotidine (H₂RA) 20 mg IV q12h

C. Infection Prevention Strategies

Ventilator-associated pneumonia (VAP) bundle

  • Elevate head of bed 30–45°
  • Daily sedation interruption and extubation assessment
  • Oral care with chlorhexidine

Central line-associated bloodstream infection (CLABSI) bundle

  • Maximal sterile barriers at insertion
  • Chlorhexidine dressings, daily line necessity review

General measures

  • Rigorous hand hygiene
  • Antimicrobial stewardship

Editor’s Note

Insufficient source material for detailed coverage. A complete section would include rates of VAP/CLABSI, specific stewardship protocols, and outcomes data.

III. Management of Iatrogenic Complications

Short summary: Recognize and reverse complications from overly rapid BP lowering and drug toxicities.

A. Overcorrection-Induced Ischemia

Recognition

  • New focal neurologic deficits, chest pain, oliguria, rising creatinine

Immediate actions

  • Slow or stop antihypertensive infusion
  • Raise BP target (MAP +10-15 mm Hg), consider small IV fluid bolus
  • Low-dose vasopressors (norepinephrine 0.01–0.05 µg/kg/min) if hypovolemia excluded

Prevention

  • Limit initial BP reduction to ≤25% within first hour (except aortic dissection, eclampsia)
Pearl Icon A shield with an exclamation mark, indicating a clinical pearl. Key Clinical Pearl: Overcorrection Ischemia

Loss of autoregulation in chronic hypertension increases ischemic risk when BP falls too fast.

B. Drug-Induced Organ Dysfunction

Nitroprusside toxicity

  • Mechanism: cyanide and thiocyanate accumulation during high-dose/prolonged infusion
  • Monitoring: lactate, methemoglobin, thiocyanate levels, renal function
  • Treatment: discontinue nitroprusside, give sodium thiosulfate (150 mg/kg IV over 15 min), consider hemodialysis

Other considerations

  • Excessive diuresis → prerenal AKI
  • Evaluate for methemoglobinemia with nitrates

IV. Multidisciplinary Goals-of-Care Conversations

Short summary: Early, structured discussions align high-burden therapies with patient values and prognosis.

A. Indications

  • Refractory shock, multi-organ failure
  • Need for mechanical circulatory support or prolonged life support
  • Poor baseline functional status or terminal illness

B. Stakeholder Involvement

  • ICU team: physicians, pharmacists
  • Nursing staff: bedside assessment, family updates
  • Palliative care: symptom management, prognostication
  • Social work/ethics: psychosocial support, advance directives

C. Communication Frameworks

  • SPIKES: Setting, Perception, Invitation, Knowledge, Empathy, Strategy/Summary
  • NURSE statements: Name emotion, Understand, Respect, Support, Explore
  • Document patient values, advance directives, and agreed-upon care plans
Pearl Icon A shield with an exclamation mark, indicating a clinical pearl. Key Clinical Pearl: Goals-of-Care

Structured goals-of-care conversations reduce nonbeneficial treatments and ICU length of stay.

References

  1. Whelton PK, Carey RM, Aronow WS, et al. 2017 ACC/AHA guideline for prevention, detection, evaluation, and management of high blood pressure in adults. Hypertension. 2018;71(6):e13–e115.
  2. Rossi GP, Rossitto G, Maifredini C, et al. Management of hypertensive emergencies: a practical approach. Blood Pressure. 2021;30(4):208–219.
  3. Hemphill JC 3rd, Greenberg SM, Anderson CS, et al. Guidelines for the management of spontaneous intracerebral hemorrhage. Stroke. 2015;46(7):2032–2060.
  4. Powers WJ, Rabinstein AA, Ackerson T, et al. Guidelines for the early management of patients with acute ischemic stroke: 2019 update. Stroke. 2019;50(12):e344–e418.
  5. Anderson CS, Heeley E, Huang Y, et al. Antihypertensive treatment of acute intracerebral hemorrhage. N Engl J Med. 2013;368(25):2355–2365.